Global Information
회사소개 | 문의 | 비교리스트

세계의 혈액 스크리닝 시장 예측(-2025년) : 핵산 증폭(실시간 PCR), ELISA(화학발광 면역측정), 신속 검사, 웨스턴 블롯

Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User-Global Forecast to 2025

리서치사 MarketsandMarkets
발행일 2020년 06월 상품 코드 949913
페이지 정보 영문 239 Pages
가격
US $ 4,950 ₩ 5,849,000 PDF (Single User License)
US $ 6,650 ₩ 7,858,000 PDF (5-user License)
US $ 8,150 ₩ 9,631,000 PDF (Corporate License)
US $ 10,000 ₩ 11,818,000 PDF (Global License)


세계의 혈액 스크리닝 시장 예측(-2025년) : 핵산 증폭(실시간 PCR), ELISA(화학발광 면역측정), 신속 검사, 웨스턴 블롯 Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User-Global Forecast to 2025
발행일 : 2020년 06월 페이지 정보 : 영문 239 Pages

세계의 혈액 스크리닝 시장은 예측기간 중 12.8%의 CAGR로 확대되어 2020년 19억 달러에서 2025년에는 35억 달러 규모로 성장할 것으로 예측됩니다. 헌혈 수요 증가, 헌혈수 증가, 감염증 확대, 새로운 병원체 만연 등의 요인이 시장 성장을 추진하고 있습니다. 기술 진보 및 신흥 국가가 참여 사업자에게 성장 기회를 나타낼 전망입니다. 그러나 가격 하락이 새로운 시장 성장 과제가 될 전망입니다. 최종사용자별로 보면 혈액은행 부문이 2019년에 큰 점유율을 차지하고, 예측기간 중에도 최대의 성장을 나타낼 전망입니다. 헌혈 수요 증가, 장기 이식 수술 증가, 혈액 안전성에 관한 인식 확산, 공익 신탁에 대한 정부 자금 투입 확대 등의 요인이 이 부문의 성장을 촉진할 전망입니다.

세계의 혈액 스크리닝 시장을 조사했으며, 시장 정의와 개요, COVID-19 및 기타 시장 영향요인 분석, 시장 규모 추정과 예측, 제품 및 서비스·기술·최종사용자·지역/주요 국가 등 각종 세분화별 내역, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

  • 시장 역학
  • COVID-19의 영향
  • 인접 시장

제6장 시장 분석과 예측 : 제품 및 서비스별

  • 시약·키트
    • NAT
    • ELISA
    • 기타
  • 기기
    • 렌탈
    • 구입
  • 소프트웨어·서비스

제7장 시장 분석과 예측 : 기술별

  • 핵산 검사
    • TMA
    • 실시간 PCR
  • ELISA
    • 화학발광 면역측정
    • 형광 면역측정
    • 비색 면역측정
  • 신속 검사
  • 웨스턴 블롯 어세이
  • 차세대 시퀀싱

제8장 시장 분석과 예측 : 최종사용자별

  • 혈액은행
  • 병원

제9장 시장 분석과 예측 : 지역·주요 국가별

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제10장 경쟁 상황

  • 개요
  • 시장 점유율 분석
  • 경쟁 시나리오
  • 경쟁 리더십 매핑

제11장 기업 개요

  • GRIFOLS
  • F. HOFFMANN-LA ROCHE
  • ABBOTT LABORATORIES
  • BIOMERIEUX
  • BIO-RAD LABORATORIES
  • BECTON, DICKSON AND COMPANY
  • DANAHER CORPORATION
  • ORTHO CLINICAL DIAGNOSTICS
  • SIEMENS HEALTHINEERS
  • THERMO FISHER SCIENTIFIC
  • DIASORIN
  • GE HEALTHCARE
  • MERCK KGAA
  • PERKINELMER
  • BIO-TECHNE
  • GFE
  • TRINITY BIOTECH
  • J. MITRA DIAGNOSTICS PVT. LTD.

제12장 인접 시장·관련 시장

제13장 부록

KSM 20.08.06

"Increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are driving the overall growth of the blood screening market"

The blood screening market is projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 12.8%. Growth in this market is driven by the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens. Technological advancements and developing economies are expected to present opportunities for growth for players in the blood screening market. However, the need to reduce blood screening prices is a major factor in challenging market growth.

Attractive Opportunities in the Blood Screening Market (2020- 2025)

COVID-19 Impact Analysis (2020-2025)

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020. This pandemic has disrupted growth in many economies across various domains. COVID-19 outbreak led to curfews and lockdown worldwide, leading to stalled blood donations, decreased/ cancelled collection drives, reduced demand for donated blood and has adversely affected the growth of blood screening market during the forecasted period globally. As stringencies with respect to curfews and social distancing become more liberal, the demand is expected to grow creating a deficit in the market. However, governments globally are taking initiatives to increase the donation during the forecasted period, to meet the sudden rise in demand following the lockdown.

Market Dynamics

Globally, the demand for donated blood is rising because of advancements in healthcare systems and the availability of and need for sophisticated surgical procedures, such as cardiovascular and transplant surgery, trauma care, and therapy for cancer and blood diseases. Blood transfusion is usually prescribed in complicated childbirths to prepare for childhood acute anaemia, trauma, and congenital maternal blood disorders. Road traffic accidents are another important consideration; blood transfusions are often required in the treatment of injuries arising out of road accidents. Moreover, rising prevalence of infectious diseases is another major factor driving the demand for effective blood screening (due to the risk of disease transmission during blood transfusion). Rising incidences of such factors are expected to drive the demand for blood transfusions and thereby will drive the growth for blood screening market.

Emerging markets such as India, China, and Southeast Asia offer promising opportunities for the players in the blood screening industry due to their increasing disposable incomes and improving healthcare infrastructure.

However, even though NAT is a superior and most reliable technology available across the globe, it is the most expensive technique in this market. Hence the emerging economies and low- income economies rely on ELISA over NAT. This is a major inhibitor for the growth of the blood screening market for NAT in the current timeframe.

"Nucleic Acid Testing (NAT) segment accounted for the larger share of the blood screening market, by technology, in 2019"

The blood screening market, by technology, has been segmented into nucleic acid testing (NAT), enzyme-linked immunosorbent assays (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). The NAT segment dominates the blood screening market, by technology, primarily due to the increasing number of blood donations and the increasing adoption of NAT technology due to its higher sensitivity over other blood screening technologies. Based on type, the blood screening market for NAT is segmented into transcription-mediated amplification (TMA) and real-time PCR. Among these, the TMA segment accounts for the larger market share due to the higher sensitivity of this assay.

"Blood banks to register the highest growth in the blood screening market during the forecast period"

Based on end users, the blood screening market is segmented into blood banks and hospitals. The blood bank segment accounted for the larger market share in 2019 and is projected to witness a higher growth rate during the forecast period. This can be attributed to the increasing demand for donated blood, a growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, increasing the number of donations worldwide, and growth in government funding to charitable trusts.

"North America will continue to dominate the blood screening market during the forecast period"

Based on region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest market share, followed by Europe. Factors such as the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens, the presence of high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the blood screening market in North America.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 36%, Tier 2 - 45%, and Tier 3 - 19%
  • By Designation: C-level - 33%, D-level - 40%, and Others - 27%
  • By Region: North America - 39%, Europe - 28%, Asia Pacific - 19%, Latin America- 9% and the Middle East and Africa- 5%

Top 5 players in the blood screening market (2020- 2025)

  • F. Hoffmann-La Roche AG (Switzerland)
  • Grifols (Spain)
  • Abbott Laboratories (US)
  • BioMerieux (France)
  • Bio-Rad Laboratories (US)

Companies Profiled in the Report:

Prominent players in the blood screening market include Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioMerieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical Diagnostics, Inc. (US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India).

Research Coverage:

This report provides a detailed picture of the global blood screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, technology, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall blood screening market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, opportunities, and trends.

Frequently asked questions:

  • Where will these developments take the industry in the mid-to-long term?
  • What are the recent trends affecting the blood screening market?
  • Who are the key players in the market, and how intense is the competition?
  • What are the key applications of blood screening instruments and consumables?
  • Which region is lucrative for the blood screening market?

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • TABLE 1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    • 2.3.3 GROWTH FORECAST
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 4 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 5 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 6 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
    • FIGURE 7 BLOOD SCREENING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 BLOOD SCREENING MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 BLOOD SCREENING MARKET OVERVIEW
    • FIGURE 9 INCREASING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
  • 4.2 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD BILLION)
    • FIGURE 10 REAGENTS & KITS SEGMENT DOMINATES THE BLOOD SCREENING MARKET
  • 4.3 BLOOD SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 11 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for donated blood and rising number of blood donations
    • TABLE 2 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
      • 5.2.1.2 Rising prevalence of infectious diseases and the emergence of newer pathogens
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Technological advancements
      • 5.2.2.2 Emerging economies
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Need for reducing blood screening prices
  • 5.3 COVID-19 IMPACT ON THE BLOOD SCREENING MARKET
  • 5.4 ADJACENT MARKETS
    • TABLE 3 ADJACENT MARKETS FOR BLOOD SCREENING MARKET (USD MILLION)

6 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 4 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 5 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
  • 6.2 REAGENTS & KITS
    • TABLE 6 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 7 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • TABLE 8 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 9 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • 6.2.1 NAT REAGENTS & KITS
      • 6.2.1.1 High sensitivity and rising use of NAT are boosting demand for related reagents and kits
    • TABLE 10 NAT REAGENTS & KITS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 11 NAT REAGENTS & KITS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • TABLE 12 NAT REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 13 NAT REAGENTS & KITS MARKET, BY TYPE, 2021-2025 (USD MILLION)
      • 6.2.1.2 Enzymes & polymerases
      • 6.2.1.3 Standards & controls
      • 6.2.1.4 Probes & primers
      • 6.2.1.5 Buffers, nucleotides, and solutions
      • 6.2.1.6 Labeling & detection reagents
    • 6.2.2 ELISA REAGENTS & KITS
      • 6.2.2.1 Ease of use and cost-effectiveness of ELISA reagents & kits will drive market growth
    • TABLE 14 ELISA REAGENTS & KITS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 15 ELISA REAGENTS & KITS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • TABLE 16 ELISA REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 17 ELISA REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
      • 6.2.2.2 Immunosorbents
      • 6.2.2.3 Controls
      • 6.2.2.4 Conjugates
      • 6.2.2.5 Substrates
      • 6.2.2.6 Sample diluents & wash solutions
    • 6.2.3 OTHER REAGENTS & KITS
      • 6.2.3.1 Increasing use of western blot tests and rapid tests will drive the growth of this market segment
    • TABLE 18 OTHER REAGENTS & KITS MARKET, BY REGION, 2018-2020 (USD MILLION)
    • TABLE 19 OTHER REAGENTS & KITS MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 20 BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 21 BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • TABLE 22 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 23 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • 6.3.1 RENTAL PURCHASE
      • 6.3.1.1 Convenience and cost-effectiveness of renting instruments has resulted in a greater end-user preference
    • TABLE 24 MARKET FOR RENTAL PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 25 MARKET FOR RENTAL PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2020-2025 (USD MILLION)
    • 6.3.2 OUTRIGHT PURCHASE
      • 6.3.2.1 Availability of government support will increase the outright purchase of instruments
    • TABLE 26 MARKET FOR OUTRIGHT PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 27 MARKET FOR OUTRIGHT PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2020-2025 (USD MILLION)
  • 6.4 SOFTWARE & SERVICES
    • 6.4.1 INCREASING ADOPTION OF INSTRUMENTS WILL DRIVE THE DEMAND FOR RELATED SOFTWARE AND SERVICES
    • TABLE 28 BLOOD SCREENING SOFTWARE & SERVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 29 BLOOD SCREENING SOFTWARE & SERVICES MARKET, BY REGION, 2020-2025 (USD MILLION)

7 BLOOD SCREENING MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 30 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 31 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
  • 7.2 NUCLEIC ACID TESTING
    • TABLE 32 BLOOD SCREENING MARKET FOR NAT, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 33 BLOOD SCREENING MARKET FOR NAT, BY REGION, 2020-2025 (USD MILLION)
    • TABLE 34 BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 35 BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • 7.2.1 TRANSCRIPTION-MEDIATED AMPLIFICATION
      • 7.2.1.1 High sensitivity of these assays to support market growth
    • TABLE 36 TRANSCRIPTION-MEDIATED AMPLIFICATION MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 37 TRANSCRIPTION-MEDIATED AMPLIFICATION MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 7.2.2 REAL-TIME POLYMERASE CHAIN REACTION
      • 7.2.2.1 Real-time PCR procedures provide more accurate and effective results as compared to conventional PCR
    • TABLE 38 REAL-TIME PCR MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 39 REAL-TIME PCR MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 7.3 ENZYME-LINKED IMMUNOSORBENT ASSAY
    • TABLE 40 BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 41 BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2020-2025 (USD MILLION)
    • TABLE 42 BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 43 BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • 7.3.1 CHEMILUMINESCENCE IMMUNOASSAY
      • 7.3.1.1 CLIA is ultrasensitive, automated, and a good alternative to conventional methodologies
    • TABLE 44 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 45 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 7.3.2 FLUORESCENT IMMUNOASSAY
      • 7.3.2.1 Rising demand for safer and stable reagents and the development of novel markers to support the growth of this market segment
    • TABLE 46 FLUORESCENT IMMUNOASSAYS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 47 FLUORESCENT IMMUNOASSAYS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 7.3.3 COLORIMETRIC IMMUNOASSAYS
      • 7.3.3.1 CI offers low sensitivity as it uses vulnerable/limited signal amplification strategies
    • TABLE 48 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 49 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 7.4 RAPID TESTS
    • 7.4.1 RISING AWARENESS ABOUT RAPID TESTS IN EMERGING COUNTRIES TO DRIVE MARKET GROWTH
    • TABLE 50 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 51 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2020-2025 (USD MILLION)
  • 7.5 WESTERN BLOT ASSAYS
    • 7.5.1 GROWING PREVALENCE OF TTIS IN DEVELOPING COUNTRIES HAS RESULTED IN THE INCREASED DEMAND FOR WESTERN BLOT ASSAYS
    • TABLE 52 BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 53 BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2020-2025 (USD MILLION)
  • 7.6 NEXT-GENERATION SEQUENCING
    • 7.6.1 NGS IS AN EMERGING TECHNOLOGY IN THE BLOOD SCREENING MARKET
    • TABLE 54 BLOOD SCREENING MARKET FOR NGS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 55 BLOOD SCREENING MARKET FOR NGS, BY REGION, 2020-2025 (USD MILLION)

8 BLOOD SCREENING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 56 BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 57 BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
  • 8.2 BLOOD BANKS
    • 8.2.1 BLOOD BANKS HOLD THE LARGEST SHARE OF THE BLOOD SCREENING MARKET
    • TABLE 58 BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 59 BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2020-2025 (USD MILLION)
  • 8.3 HOSPITALS
    • 8.3.1 INCREASING G NUMBER OF SURGICAL PROCEDURES WILL DRIVE THE GROWTH OF THE HOSPITALS SEGMENT
    • TABLE 60 BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 61 BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2020-2025 (USD MILLION)

9 BLOOD SCREENING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 62 BLOOD SCREENING MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 63 BLOOD SCREENING MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 12 NORTH AMERICA: BLOOD SCREENING MARKET SNAPSHOT
    • TABLE 64 NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 65 NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 66 NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 67 NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 68 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 69 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 70 NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 71 NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 72 NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 73 NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 74 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 75 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 76 NORTH AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 77 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 78 NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 79 NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US dominates the global blood screening market
      • 9.2.1.2 COVID-19 Impact Analysis
    • TABLE 80 INCIDENCE OF VARIOUS CANCERS IN THE US, 2018 VS. 2025
    • TABLE 81 US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 82 US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 83 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 84 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 85 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 86 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 87 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 88 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 89 US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 90 US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 91 US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 92 US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 93 US: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 94 US: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Growing volume of surgical procedures performed and the high burden of cancer to support market growth
      • 9.2.2.2 COVID-19 Impact Analysis
    • TABLE 95 CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 96 CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 97 CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 98 CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 99 CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 100 CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 101 CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 102 CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 103 CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 104 CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 105 CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 106 CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 107 CANADA: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 108 CANADA: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 109 EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 110 EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 111 EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 112 EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 113 EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 114 EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 115 EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 116 EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 117 EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 118 EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 119 EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 120 EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 121 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 122 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 123 EUROPE: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 124 EUROPE: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany is the largest market for blood screening technologies in Europe
      • 9.3.1.2 COVID-19 Impact Analysis
    • TABLE 125 GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 126 GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 127 GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 128 GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 129 GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 130 GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 131 GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 132 GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 133 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 134 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 135 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 136 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 137 GERMANY: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 138 GERMANY: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Increasing prevalence of HIV to support market growth
    • TABLE 139 FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 140 FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 141 FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 142 FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 143 FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 144 FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 145 FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 146 FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 147 FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 148 FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 149 FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 150 FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 151 FRANCE: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 152 FRANCE: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Government support to prevent transmission of HIV and other infections will drive market growth
      • 9.3.3.2 COVID-19 Impact Analysis
    • TABLE 153 UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 154 UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 155 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 156 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 157 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 158 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 159 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 160 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 161 UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 162 UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 163 UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 164 UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 165 UK: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 166 UK: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Italy is witnessing an increase in the number of blood donors
      • 9.3.4.2 COVID-19 Impact Analysis
    • TABLE 167 ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 168 ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 169 ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 170 ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 171 ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 172 ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 173 ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 174 ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 175 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 176 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 177 ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 178 ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 179 ITALY: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 180 ITALY: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing adoption of NAT technology will support market growth
    • TABLE 181 SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 182 SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 183 SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 184 SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 185 SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 186 SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 187 SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 188 SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 189 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 190 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 191 SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 192 SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 193 SPAIN: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 194 SPAIN: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 195 ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 196 ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 197 ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 198 ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 199 ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 200 ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 201 ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 202 ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 203 ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 204 ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 205 ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 206 ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 207 ROE: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 208 ROE: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 13 ASIA PACIFIC: BLOOD SCREENING MARKET SNAPSHOT
    • TABLE 209 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 210 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 211 ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 212 ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 213 ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 214 ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 215 ASIA PACIFIC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION) 146
    • TABLE 216 ASIA PACIFIC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 217 ASIA PACIFIC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 218 ASIA PACIFIC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 219 ASIA PACIFIC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 220 ASIA PACIFIC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 221 ASIA PACIFIC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 222 ASIA PACIFIC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 223 ASIA PACIFIC: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 224 ASIA PACIFIC: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China has a high prevalence of infectious diseases
      • 9.4.1.2 COVID-19 Impact Analysis
    • TABLE 225 CHINA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 226 CHINA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 227 CHINA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 228 CHINA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 229 CHINA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 230 CHINA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 231 CHINA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 232 CHINA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 233 CHINA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 234 CHINA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 235 CHINA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 236 CHINA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 237 CHINA: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 238 CHINA: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Japan has witnessed an increase in the adoption of advanced blood screening technologies
      • 9.4.2.2 COVID-19 Impact Analysis
    • TABLE 239 JAPAN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 240 JAPAN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 241 JAPAN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 242 JAPAN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 243 JAPAN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 244 JAPAN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 245 JAPAN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 246 JAPAN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 247 JAPAN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 248 JAPAN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 249 JAPAN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 250 JAPAN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 251 JAPAN: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 252 JAPAN: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Increasing number of road accidents will support market growth
      • 9.4.3.2 COVID-19 Impact Analysis
    • TABLE 253 INDIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 254 INDIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 255 INDIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 256 INDIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 257 INDIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 258 INDIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 259 INDIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 260 INDIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 261 INDIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 262 INDIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 263 INDIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 264 INDIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 265 INDIA: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 266 INDIA: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Rising number of blood donations will propel market growth
    • TABLE 267 AUSTRALIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 268 AUSTRALIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 269 AUSTRALIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 270 AUSTRALIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 271 AUSTRALIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 272 AUSTRALIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 273 AUSTRALIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 274 AUSTRALIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 275 AUSTRALIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 276 AUSTRALIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 277 AUSTRALIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 278 AUSTRALIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 279 AUSTRALIA: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 280 AUSTRALIA: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.4.5 REST OF ASIA PACIFIC
    • TABLE 281 ROAPAC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 282 ROAPAC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 283 ROAPAC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 284 ROAPAC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 285 ROAPAC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 286 ROAPAC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 287 ROAPAC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 288 ROAPAC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 289 ROAPAC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 290 ROAPAC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 291 ROAPAC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 292 ROAPAC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 293 ROAPAC: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 294 ROAPAC: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 295 LATIN AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 296 LATIN AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 297 LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 298 LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 299 LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 300 LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 301 LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 302 LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 303 LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 304 LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 305 LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 306 LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 307 LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 308 LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 309 LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 310 LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.5.1 BRAZIL
      • 9.5.1.1 Increasing incidence of cancer will support the growth of this market
    • TABLE 311 INCIDENCE OF VARIOUS CANCERS IN BRAZIL, 2018 VS. 2025
    • TABLE 312 BRAZIL: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 313 BRAZIL: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 314 BRAZIL: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 315 BRAZIL: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 316 BRAZIL: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 317 BRAZIL: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 318 BRAZIL: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 319 BRAZIL: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 320 BRAZIL: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 321 BRAZIL: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 322 BRAZIL: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 323 BRAZIL: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 324 BRAZIL: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 325 BRAZIL: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.5.2 REST OF LATIN AMERICA
    • TABLE 326 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 327 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 328 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 329 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 330 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 331 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 332 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 333 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 334 REST OF LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 335 REST OF LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 336 REST OF LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 337 REST OF LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 338 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 339 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 RISING PREVALENCE OF INFECTIOUS DISEASES WILL DRIVE MARKET GROWTH IN THE REGION
    • TABLE 340 MEA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2019 (USD MILLION)
    • TABLE 341 MEA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION)
    • TABLE 342 MEA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 343 MEA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 344 MEA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016-2019 (USD MILLION)
    • TABLE 345 MEA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020-2025 (USD MILLION)
    • TABLE 346 MEA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
    • TABLE 347 MEA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
    • TABLE 348 MEA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 349 MEA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 350 MEA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016-2019 (USD MILLION)
    • TABLE 351 MEA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020-2025 (USD MILLION)
    • TABLE 352 MEA: BLOOD SCREENING MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 353 MEA: BLOOD SCREENING MARKET, BY END USER, 2020-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 14 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2019
  • 10.2 MARKET SHARE ANALYSIS, 2019
    • 10.2.1 MARKET SHARE ANALYSIS FOR NAT BLOOD SCREENING, 2019
    • FIGURE 15 NAT BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
    • 10.2.2 MARKET SHARE ANALYSIS FOR TOTAL BLOOD SCREENING, 2019
    • FIGURE 16 BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017-2019)
    • 10.3.2 PRODUCT LAUNCHES (2017-2019)
    • 10.3.3 EXPANSIONS (2017-2019)
    • 10.3.4 ACQUISITIONS (2017-2019)
  • 10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
    • 10.4.1 VENDOR INCLUSION CRITERIA
    • 10.4.2 VISIONARY LEADERS
    • 10.4.3 INNOVATORS
    • 10.4.4 DYNAMIC DIFFERENTIATORS
    • 10.4.5 EMERGING COMPANIES
    • FIGURE 17 BLOOD SCREENING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, and MnM View)**

  • 11.1 GRIFOLS
    • FIGURE 18 GRIFOLS: COMPANY SNAPSHOT (2019)
  • 11.2 F. HOFFMANN-LA ROCHE
    • FIGURE 19 F. HOFFMAN-LA ROCHE: COMPANY SNAPSHOT (2019)
  • 11.3 ABBOTT LABORATORIES
    • FIGURE 20 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
  • 11.4 BIOMERIEUX
    • FIGURE 21 BIOMERIEUX: COMPANY SNAPSHOT (2018)
  • 11.5 BIO-RAD LABORATORIES
    • FIGURE 22 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
  • 11.6 BECTON, DICKSON AND COMPANY
    • FIGURE 23 BECTON, DICKSON AND COMPANY: COMPANY SNAPSHOT (2019)
  • 11.7 DANAHER CORPORATION
    • FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
  • 11.8 ORTHO CLINICAL DIAGNOSTICS
  • 11.9 SIEMENS HEALTHINEERS
    • FIGURE 25 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
  • 11.10 THERMO FISHER SCIENTIFIC
    • FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
  • 11.11 DIASORIN
    • FIGURE 27 DIASORIN: COMPANY SNAPSHOT (2019)
  • 11.12 GE HEALTHCARE
    • FIGURE 28 GENERAL ELECTRIC: COMPANY SNAPSHOT (2019)
  • 11.13 MERCK KGAA
    • FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2019)
  • 11.14 PERKINELMER
    • FIGURE 30 PERKINELMER: COMPANY SNAPSHOT (2019)
  • 11.15 BIO-TECHNE
    • FIGURE 31 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2019)

* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

  • 11.16 GFE
  • 11.17 TRINITY BIOTECH
  • 11.18 J. MITRA DIAGNOSTICS PVT. LTD.

12 ADJACENT/ RELATED MARKET- IMMUNOASSAY MARKET

  • 12.1 INTRODUCTION
  • 12.2 IMMUNOASSAY MARKET
    • 12.2.1 MARKET DEFINITION
    • 12.2.2 LIMITATIONS
    • 12.2.3 MARKET OVERVIEW
  • 12.3 IMMUNOASSAY MARKET, BY PRODUCT AND SERVICE
    • TABLE 354 IMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
    • TABLE 355 IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
    • 12.3.1 REAGENTS & KITS
    • TABLE 356 IMMUNOASSAY REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
      • 12.3.1.1 Reagents & Kits Market, By Type
    • TABLE 357 IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • 12.3.1.1.1 ELISA Reagents & Kits
    • TABLE 358 ELISA REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
        • 12.3.1.1.2 Rapid Test Reagents & Kits
    • TABLE 359 RAPID TEST REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
        • 12.3.1.1.3 ELISPOT Reagents & Kits
    • TABLE 360 ELISPOT REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
        • 12.3.1.1.4 Western blot reagents & kits
    • TABLE 361 WESTERN BLOT REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
        • 12.3.1.1.5 Other reagents & kits
    • TABLE 362 OTHER REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • 12.4 ANALYZERS
    • TABLE 363 IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2016-2023 (USD MILLION)
    • TABLE 364 IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
    • 12.4.1 OPEN-ENDED SYSTEMS
    • TABLE 365 OPEN-ENDED SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
    • 12.4.2 CLOSED-ENDED SYSTEMS
    • TABLE 366 CLOSED-ENDED SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
    • 12.4.3 IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE
    • TABLE 367 IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • 12.5 SOFTWARE & SERVICES
    • TABLE 368 IMMUNOASSAY SOFTWARE & SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • 12.6 MOLECULAR DIAGNOSTICS MARKET
    • TABLE 369 MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
    • TABLE 370 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • 12.7 WESTERN BLOTTING MARKET
    • TABLE 371 WESTERN BLOTTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • 12.8 IN-VITRO DIAGNOSTICS MARKET
    • TABLE 372 IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2019-2025 (USD MILLION)

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS 253
Back to Top
전화 문의
F A Q